Diana Urbauer, M.S.

Principal Statistical Analyst

Education

• M.S. in Statistics, Texas A&M University, College Station, TX
• B.S. in Statistics and Operations Research, University of Illinois at Chicago, Chicago, IL

Publications 

2012

Fingeret MC, Yuan Y, Urbauer D, Weston J, Nipomnick S, Weber R.  The nature and extent of body image concerns among surgically treated patients with head and neck cancer.  Psycho-Oncology 2012; [Advance publication online, doi: 10.1002/pon.1990]

Bartley AN, Luthra R, Saraiya DS, Urbauer DL, Broaddus, RR.  Identification of cancer patients with Lynch syndrome: Clinically significant discordances and problems in tissue-based mismatch repair testing. Cancer Prev Res (Phila) 2012;  [Advance publication online,  PMID:22086678]

2011

Chiong E, Lee IL, Dadbin A, Sabichi AL, Harris LD, Urbauer DL, McConkey DJ, Dickstein RJ, Cheng T, Grossman HB.  Effects of mTOR inhibitor everolimus (RAD001) on bladder cancer cells. Clin Cancer Res 2011; 17(9):2863-2873.

Badr H, Paxton RJ, Ater JL, Urbauer D, Demark-Wahnefried W.  Health behaviors and weight status of childhood cancer survivors and their parents: Similarities and opportunities for joint intervention. J Am Diet Assoc 2011; 111(12):1917-1923.  

Lacour RA, Westin SN, Meyer LA, Wingo SN, Schorge JO, Brooks R, Mutch D, Molina A, Sutphen R, Barnes M, Elder J, Teoh D, Powell CB, Choubey V, Blank S, Macdonald HR, Brady MF, Urbauer DL, Bodurka D, Gershenson DM, Lu KH. Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations. Gynecol Oncol 2011; 121(2):358-363.

Schlumbrecht MP, Xie SS, Shipley GL, Urbauer DL, Broaddus RR. Molecular clustering based on ERα and EIG121 predicts survival in high-grade serous carcinoma of the ovary/peritoneum. Mod Pathol 2011; 24(3):453-462.

Vineyard MA, Daniels MS, Urbauer DL, Deavers MT, Sun CC, Boerwinkle E, Bodurka DC, Gershenson DM, Crawford J, Lu KH. Is low-grade serous ovarian cancer part of the tumor spectrum of hereditary breast and ovarian cancer? Gynecol Oncol 2011; 120(2):229-232.

Burzawa JK, Schmeler KM, Soliman PT, Meyer LA, Bevers MW, Pustilnik TL, Anderson ML, Ramondetta LM, Tortolero-Luna G, Urbauer DL, Chang S, Gershenson DM, Brown J, Lu KH. Prospective evaluation of insulin resistance among endometrial cancer patients. Am J Obstet Gynecol 2011; 204(4):355.e1-7.

Ramondetta L, Brown A, Richardson G, Urbauer D, Thaker PH, Koenig HG, Gano JB, Sun C. Religious and spiritual beliefs of gynecologic oncologists may influence medical decision making. Int J Gynecol Cancer 2011; 21(3):573-581.

Yennurajalingam S, Urbauer DL, Casper KL, Reyes-Gibby CC, Chacko R, Poulter V, Bruera E. Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic. J Pain Symptom Manage 2011; 41(1):49-56.

Cofta-Woerpel L, McClure JB, Li Y, Urbauer D, Cinciripini PM, Wetter DW.  Early cessation success or failure among women attempting to quit smoking: Trajectories and volatility of urge and negative mood during the first postcessation week. J Abnorm Psychol 2011; 120(3):596-606.

Ramondetta LM, Diana Urbauer D, Brown AJ, Richardson G, Thaker PH, Koenig HG, Levenback C, Sun C.  Work related stress among gynecologic oncologists. Gynecol Oncol 2011; 123(2):365-369.

2010

Mazloom A, Medeiros LJ, McLaughlin PW, Reed V, Cabanillas FF, Fayad LE, Pro B, Gonzalez G, Iyengar P, Urbauer DL, Dabaja BS. Marginal zone lymphomas: factors that affect the final outcome. Cancer 2010; 116(18):4291-4298.

Svatek RS, Fisher MB, Williams MB, Matin SF, Kamat AM, Grossman HB, Nogueras-Gonzalez GM, Urbauer DL, Dinney CP. Age and body mass index are independent risk factors for the development of postoperative paralytic ileus after radical cystectomy. Urology 2010; 76(6):1419-1424.

Meyer LA, Anderson ME, Lacour RA, Suri A, Daniels MS, Urbauer DL, Nogueras-Gonzalez GM, Schmeler KM, Gershenson DM, Lu KH. Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities. Obstet Gynecol 2010; 115(5): 945-952.

Kamat AA, Baldwin M, Urbauer D, Dang D, Han LY, Godwin A, Karlan BY, Simpson JL, Gershenson DM, Coleman RL, Bischoff FZ, Sood AK. Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker. Cancer 2010; 116(8): 1918-1925.

Wham D, VU T, Chan-Smutko G, Kobelka C, Urbauer D, Heald B. Assessment of clinical practices among cancer genetic counselors. Fam Cancer 2010; 9(3): 459-468.

Svatek RS, Fisher MB, Matin SF, Kamat AM, Grossman HB, Nogueras-Gonzalez GM, Urbauer DL, Kennedy KA, Dinney CP. Risk factor analysis in a contemporary cystectomy cohort using standardized reporting methodology and adverse event criteria. J Urol 2010; 183(3): 929-934.

2009 and earlier

Westin SN, Broaddus RR, Deng L, McCampbell A, Lu KH, Lacour RA, Milam MR, Urbauer DL, Mueller P, Pickar JH, Loose DS. Molecular clustering of endometrial carcinoma based on estrogen-induced gene expression. Cancer Biol Ther 2009; 8(22): 2126-2135.

Daniels MS, Urbauer DL, Stanley JL, Johnson KG, Lu KH. Timing of BRCA1/BRCA2 genetic testing in women with ovarian cancer. Genet Med 2009; 11(9): 624-628.

Kamat AA, Coffey D, Merritt WM, Nugent E, Urbauer D, Lin YG, Edwards C, Broaddus R, Coleman RL, Sood AK. EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer. Cancer 2009; 115(12): 2684-2692.

Jaishuen A, Jimenez C, Sirisabya N, Li Y, Zheng H, Hu W, Urbauer DL, Kavanagh JJ. Poor survival outcome with moderate and severe hypercalcemia in gynecologic malignancy patients. Int J Gynecol Cancer 2009; 19(2): 178-185.

Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R, Urbauer D, Pennacchio LA, Cheng JF, Nick AM, Deavers MT, Mourad-Zeidan A, Wang H, Mueller P, Lenburg ME, Gray JW, Mok S, Birrer MJ, Lopez-Berestein G, Coleman RL, Bar-Eli M, Sood AK. Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 2008; 359(25): 2641-2650.

Westin SN, Lacour RA, Urbauer DL, Luthra R, Bodurka DC, Lu KH, Broaddus RR. Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome. J Clin Oncol 2008; 26(36): 5965-5971.

Han LY, Fletcher MS, Urbauer DL, Mueller P, Landen CN, Kamat AA, Lin YG, Merritt WM, Spannuth WA, Deavers MT, De Geest K, Gershenson DM, Lutgendorf SK, Ferrone S, Sood AK. HLA class I antigen processing machinery component expression and intratumoral T-cell infiltrate as independent prognostic markers in ovarian carcinoma. Clin Cancer Res 2008; 14(11): 3372-3379.

Barnett JA, Urbauer DL, Murray GI, Fuller GN, Heimberger AB. Cytochrome P450 1B1 expression in glial cell tumors: an immunotherapeutic target. Clin Cancer Res 2007; 13(12): 3559-3567.

Lin YG, Han LY, Kamat AA, Merritt WM, Landen CN, Deavers MT, Fletcher MS, Urbauer DL, Kinch MS, Sood AK. EphA2 overexpression is associated with angiogenesis in ovarian cancer. Cancer 2007; 109(2): 332-340.

Soltero E, Petersen NJ, Earle NR, Glaeser DH, Urbauer DL, Deswal A. Long-term results of coronary artery bypass grafting in patients with ischemic cardiomyopathy: The impact of renal insufficiency and noncardiac vascular disease. J Card Fail 2005; 11(3): 206-212.

Braun UK, Rabeneck L, McCullough LB, Urbauer DL, Wray NP, Lairson DR, Beyth RJ. Decreasing use of percutaneous endoscopic gastrostomy tube feeding for veterans with dementia - racial differences remain. J Am Geriatr Soc 2005; 53(2): 242-248.

Kahan BD, Welsh M, Urbauer DL, Mosheim MB, Beusterien KM, Wood MR, Schoenberg LP, Dicesare J, Katz SM, Van Buren CT. Low intraindividual variability of cyclosporin A exposure reduces chronic rejection incidence and health care costs. J Am Soc Nephrol 2000; 11(6): 1122-1131.

Kahan BD, Napoli KL, Kelly PA, Podbielski J, Hussein I, Urbauer DL, Katz SH, Van Buren CT. Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity. Clin Transplant 2000; 14(2): 97-109.

Gruber SA, Gallichio M, Rosano TG, Kaplan SS, Hughes SE, Urbauer DL, Singh TP, Lempert N, Conti DJ, Stein DS, Drusano G. Comparative pharmacokinetics and renal effects of cyclosporin A and cyclosporin G in renal allograft recipients. J Clin Pharmacol 1997; 37(7): 575-86.

Kahan BD, Welsh M, Schoenberg L, Rutzky LP, Katz SM, Urbauer DL, Van Buren CT. Variable oral absorption of cyclosporine: a biopharmaceutical risk factor for chronic renal allograft rejection. Transplantation 1996; 62(5): 599-606.

^{Updated February 1, 2012}